Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

UBS upgrades Man Group to 'buy'

(Sharecast News) - UBS upgraded Man Group to 'buy' from 'neutral' on Thursday and lifted the price target to 365p from 335p as it pointed to a solid performance from AHL, the company's suite of trend-following funds. "We believe EMG's share price does not reflect the recent positive performance across its AHL strategies (+7%) over the past six weeks," UBS said. "In our view, this offers an attractive entry point as we expect material upgrades to consensus EPS with Q3 coming to a close at month end."

In the longer term, UBS said it views Man Group's business model positively and thinks the company, through its technology, has a sustainable competitive advantage over peers.

"We also expect institutional investors to increase allocations to Man Group's liquid alternatives and credit strategies in the coming years," it said.

UBS expects the next catalysts to be upgrades to consensus earnings per share in early October as the sell-side marks its models to market to reflect AHL's recent performance and Man Group's Q3'26 AUM release on 16 October.

At 1015 BST, the shares were up 5.3% at 333.51p.

Share this article

Related Sharecast Articles

Berenberg raises target price on Persimmon, keeps 'hold' rating
(Sharecast News) - Analysts at Berenberg raised their target price on housebuilder Persimmon from 1,150p to 1,240p on Friday after lifting their 2026-27 earnings per share estimates by an average of 2% following the group's third-quarter trading update.
Wise H1 profits climb as customer base tops 16m
(Sharecast News) - Global fintech group Wise reported a jump in first-half revenue and profits on Friday, putting the recently dual-listed firm on track to hit the upper end of its full-year growth targets.
GSK wins positive CHMP opinion for Bexsero meningitis B booster
(Sharecast News) - Pharmaceutical giant GSK said on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use had issued a positive opinion recommending a label update for its Bexsero meningitis B vaccine.
Major Microsoft outage hits hospitals, businesses and financial markets worldwide
(Sharecast News) - A global Microsoft outage has disrupted businesses, government agencies and other organisations worldwide, leaving users without a slew of vital services in what is one of the group's most prolonged service disruptions in history.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.